Caricamento...
B cell maturation antigen (BCMA)-based Immunotherapy for Multiple Myeloma
INTRODUCTION: B cell maturation antigen (BCMA) contributes to MM pathophysiology and is a target antigen for novel MM immunotherapy. Complete responses have been observed in heavily-pretreated MM patients after treatment with BCMA antibody drug conjugates (ADC), chimeric antigen receptor T, and bi-s...
Salvato in:
| Pubblicato in: | Expert Opin Biol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785394/ https://ncbi.nlm.nih.gov/pubmed/31277554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2019.1641196 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|